Biotech, obesity, Life Sciences Luke Timmerman wrote: Fen-phen was the wonder drug for weight loss in the 1990s, until it was found to damage heart valves and yanked off the market. Now the folks at San Diego-based Arena Pharmaceuticals are eagerly waiting clinical trial results that will show wheth...

The European Heart Journal has published data from a two year follow up of the Rimonabant In Obesity - Europe study. A summary of the article is available via the National Electronic Library for Medicine. The original RIO-Europe study recruited 1,057 individuals with a body mass index (BMI) of 30kg/...